These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30786941)

  • 1. A screening strategy for latent tuberculosis in healthcare workers: Cost-effectiveness and budget impact of universal versus targeted screening.
    Png ME; Yoong J; Ong CWM; Fisher D; Bagdasarian N
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):341-349. PubMed ID: 30786941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.
    Mullie GA; Schwartzman K; Zwerling A; N'Diaye DS
    BMC Med; 2017 May; 15(1):104. PubMed ID: 28514962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
    Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
    JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children.
    Laskin BL; Goebel J; Starke JR; Schauer DP; Eckman MH
    Am J Kidney Dis; 2013 Jan; 61(1):22-32. PubMed ID: 22784996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
    Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
    Di Bella S; Siroka A; Antonello RM; Zignol M; Maschio M; Tominz R; Cirillo D; Migliori GB; Confalonieri M; Raviglione M; Luzzati R
    Int J Tuberc Lung Dis; 2019 Sep; 23(9):1024-1028. PubMed ID: 31615611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
    Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
    Diel R; Lampenius N; Nienhaus A
    Pharmacoeconomics; 2015 Aug; 33(8):783-809. PubMed ID: 25774015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore.
    Lim VW; Wee HL; Lee P; Lin Y; Tan YR; Tan MX; Lin LW; Yap P; Chee CB; Barkham T; Lee V; Chen M; Ong RT
    BMJ Open; 2021 Jul; 11(7):e050629. PubMed ID: 34266845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital.
    Janagond AB; Ganesan V; Vijay Kumar GS; Ramesh A; Anand P; Mariappan M
    Int J Mycobacteriol; 2017; 6(3):253-257. PubMed ID: 28776523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.